Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2011

May 27, 2011

34117_dirs_2011-05-27_24af744e-95ec-4697-8b73-97cbe54691fb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2011-05-25

Reporting Person: KRUSOS DENIS A (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-05-25 Common Stock M 500000 $0.25 Acquired 1696880 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-05-25 Employee Stock Option $0.25 M 500000 Disposed 2013-05-05 Common Stock (500000) Direct

Footnotes

F1: Amount of securities beneficially owned represents shares held by Mr. Krusos and excludes shares Mr. Krusos has the right to acquire upon exercise of stock options pursuant to CopyTele, Inc. stock incentive plans

F2: Right-To-Buy, pursuant to the Copytele, Inc. 2003 Share Incentive Plan.